JP Stock MarketDetailed Quotes
4892 Cyfuse Biomedical KK
- 463
- -21-4.34%
20min DelayMarket Closed Nov 22 15:30 JST
3.77BMarket Cap-6138P/E (Static)
486High463Low51.60KVolume486Open484Pre Close24.37MTurnover88352wk High1.08%Turnover Ratio8.13MShares43052wk Low-84.84EPS TTM2.21BFloat Cap2468Historical HighLossP/E (Static)4.77MShs Float430Historical Low-75.42EPS LYR4.75%Amplitude--Dividend TTM1.28P/B100Lot Size--Div YieldTTM
Cyfuse Biomedical KK Key Stats
EPS
According to the latest financial report of Cyfuse Biomedical KK, the latest earnings per share (TTM) for the company is -27.77. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Cyfuse Biomedical KK's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cyfuse Biomedical KK shows that the company's current ratio is 6.11, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cyfuse Biomedical KK, the quick ratio is 5.91, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Cyfuse Biomedical KK? The latest ROE figure is -7.52%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cyfuse Biomedical KK, the total asset return on investment (ROA) is -5.75%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cyfuse Biomedical KK's latest financial report to see how their gross margin is doing - currently at 15.25%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cyfuse Biomedical KK, the net profit margin is -3.06K%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data